{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:40:27Z","timestamp":1790991627885,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-89616-7","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T06:40:45Z","timestamp":1743662445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A population based study to analyse amyotrophic lateral sclerosis as a multi-step process"],"prefix":"10.1038","volume":"15","author":[{"given":"Anna","family":"D\u2019Amico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Cucunato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Salemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo La","family":"Bella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Aridon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"89616_CR1","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","volume":"377","author":"MC Kiernan","year":"2011","unstructured":"Kiernan, M. C. et al. Amyotrophic lateral sclerosis. Lancet 377, 942\u2013955 (2011).","journal-title":"Lancet"},{"issue":"8","key":"89616_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a024117","volume":"7","author":"LI Grad","year":"2017","unstructured":"Grad, L. I., Rouleau, G. A., Ravits, J. & Cashman, N. R. Clinical spectrum of amyotrophic lateral sclerosis (ALS). Cold Spring Harb Perspect. Med. 7(8), 1\u201316. https:\/\/doi.org\/10.1101\/cshperspect.a024117 (2017).","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"89616_CR3","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.clineuro.2011.11.026","volume":"114","author":"E Cellura","year":"2012","unstructured":"Cellura, E., Spataro, R., Taiello, A. C. & La Bella, V. Factors affecting the diagnostic delay in amyotrophic lateral sclerosis. Clin. Neurol. Neurosurg. 114, 550\u2013554 (2012).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"89616_CR4","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S1474-4422(14)70129-2","volume":"13","author":"H Mitsumoto","year":"2014","unstructured":"Mitsumoto, H., Brooks, B. R. & Silani, V. Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved? Lancet Neurol. 13, 1127\u20131138 (2014).","journal-title":"Lancet Neurol."},{"key":"89616_CR5","doi-asserted-by":"crossref","unstructured":"Salmon, K. & Genge, A. Clinical Trials in ALS \u2013 Current Challenges and Strategies for Future Directions. In: Spectrums of Amyotrophic Lateral Sclerosis: Heterogeneity, Pathogenesis, and Therapeutic Directions. 1ST Edition. (Christopher A. Shaw and Jessica R. Morrice, Eds.) Chapt. 9, pg 161\u2013180. John Wiley & Sons Ltd. (2021).","DOI":"10.1002\/9781119745532.ch9"},{"key":"89616_CR6","first-page":"181","volume":"7","author":"C Ingre","year":"2015","unstructured":"Ingre, C., Roos, P. M., Piehl, F., Kamel, F. & Fang, F. Risk factors for amyotrophic lateral sclerosis. Clin. Epidemiol. 7, 181\u2013193 (2015).","journal-title":"Clin. Epidemiol."},{"key":"89616_CR7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrneurol.2013.203","volume":"9","author":"A Al-Chalabi","year":"2013","unstructured":"Al-Chalabi, A. & Hardiman, O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat. Rev. Neurol. 9, 617\u2013628 (2013).","journal-title":"Nat. Rev. Neurol."},{"issue":"R2","key":"89616_CR8","doi-asserted-by":"crossref","first-page":"R105","DOI":"10.1093\/hmg\/ddx247","volume":"26","author":"T Niccoli","year":"2017","unstructured":"Niccoli, T., Partridge, L. & Isaacs, A. M. Ageing as a risk factor for LS\/FTD. Hum. Mol. Genet. 26 (R2), R105\u2013R113 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"89616_CR9","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/1097-0142(195109)4:5<916::AID-CNCR2820040504>3.0.CO;2-7","volume":"4","author":"JC Fisher","year":"1951","unstructured":"Fisher, J. C. & Hollomon, J. H. A hypothesis for the origin of cancer foci. Cancer 4, 916\u2013918 (1951).","journal-title":"Cancer"},{"key":"89616_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1954.1","volume":"8","author":"P Armitage","year":"1954","unstructured":"Armitage, P. & Doll, R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br. J. Cancer. 8, 1\u201312 (1954).","journal-title":"Br. J. Cancer"},{"key":"89616_CR11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/bjc.1953.8","volume":"7","author":"CO Nordling","year":"1953","unstructured":"Nordling, C. O. A new theory on cancer-inducing mechanism. Br. J. Cancer. 7, 68\u201372 (1953).","journal-title":"Br. J. Cancer"},{"key":"89616_CR12","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S1474-4422(14)70219-4","volume":"13","author":"A Al-Chalabi","year":"2014","unstructured":"Al-Chalabi, A. et al. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modeling study. Lancet Neurol. 13, 1108\u20131113 (2014).","journal-title":"Lancet Neurol."},{"key":"89616_CR13","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1080\/21678421.2018.1556697","volume":"20","author":"S Vucic","year":"2019","unstructured":"Vucic, S. et al. Amyotrophic lateral sclerosis as a multistep process: an Australia population study. Amyotr Lat Scler. Frontotemp Degen. 20, 532\u2013537 (2019).","journal-title":"Amyotr Lat Scler. Frontotemp Degen"},{"issue":"15","key":"89616_CR14","doi-asserted-by":"crossref","first-page":"e1657","DOI":"10.1212\/WNL.0000000000009015","volume":"94","author":"S Vucic","year":"2020","unstructured":"Vucic, S. et al. ALS is a multistep process in South Korean, Japanese, and Australian patients. Neurology 94 (15), e1657\u2013e1663 (2020).","journal-title":"Neurology"},{"issue":"7","key":"89616_CR15","doi-asserted-by":"crossref","first-page":"e635","DOI":"10.1212\/WNL.0000000000005996","volume":"91","author":"A Chi\u00f2","year":"2018","unstructured":"Chi\u00f2, A. et al. The multistep hypothesis of ALS revisited. The role of genetic mutations. Neurology 91 (7), e635\u2013e642 (2018).","journal-title":"Neurology"},{"key":"89616_CR16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","volume":"1","author":"BR Brooks","year":"2000","unstructured":"Brooks, B. R., Miller, R. G., Swash, M., Munsat, T. L. & WFN Research Group on MND. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1, 293\u2013299 (2000).","journal-title":"Amyotroph. Lateral Scler. Other Motor Neuron Disord"},{"key":"89616_CR17","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.clinph.2020.04.005","volume":"131","author":"JM Shefner","year":"2020","unstructured":"Shefner, J. M. et al. A proposal for new diagnostic criteria for ALS. Clin. Neurophysiol. 131, 1975\u20131978 (2020).","journal-title":"Clin. Neurophysiol."},{"key":"89616_CR18","first-page":"15","volume":"29","author":"The Sicilian ALS Study Group","year":"2015","unstructured":"The Sicilian ALS Study Group. Linee Guida per la presa in Carico delle persone affette da sclerosi laterale amiotrofica (sicilian guidelines for the follow-up and management of patients with ALS). Gazz. Ufficiale Della Regione Siciliana. 29, 15\u201324 (2015).","journal-title":"Gazz. Ufficiale Della Regione Siciliana"},{"key":"89616_CR19","first-page":"1","volume":"112","author":"P De Cuesta","year":"1987","unstructured":"De Cuesta, P. Studies on the prevalence of paralysis agitans by tracer methodology. Acta Neurol. Scand. Suppl. 112, 1\u2013106 (1987).","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"89616_CR20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/21678421.2019.1674874","volume":"21","author":"F Hodgins","year":"2020","unstructured":"Hodgins, F., Mulhern, S. & Abrahams, S. The clinical impact of the Edinburgh cognitive and behavioural ALS screen (ECAS) and neuropsychological intervention in routine ALS care. Amyotroph. Lateral Scler. Frontotemporal Degener. 21, 92\u201399 (2020).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener"},{"key":"89616_CR21","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky, K. et al. Sensitivity of revised diagnostic criteria for the behavioral variant of frontotemporal dementia. Brain 134, 2456\u20132477 (2011).","journal-title":"Brain"},{"issue":"6","key":"89616_CR22","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10072-017-2919-4","volume":"38","author":"M Siciliano","year":"2017","unstructured":"Siciliano, M. et al. Edinburgh cognitive and behavioural ALS screen (ECAS)-Italian version: regression based norms and equivalent scores. Neurol. Sciences: Official J. Italian Neurol. Soc. Italian Soc. Clin. Neurophysiol. 38 (6), 1059\u20131068 (2017).","journal-title":"Neurol. Sciences: Official J. Italian Neurol. Soc. Italian Soc. Clin. Neurophysiol."},{"key":"89616_CR23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1212\/WNL.56.2.239","volume":"56","author":"Piemonte and Valle d\u2019Aosta Register for Amyotrophic Lateral Sclerosis (PARALS)","year":"2001","unstructured":"Piemonte and Valle d\u2019Aosta Register for Amyotrophic Lateral Sclerosis (PARALS). Incidence of ALS in Italy. Evidence for a uniform frequency in western countries. Neurology 56, 239\u2013244 (2001).","journal-title":"Neurology"},{"key":"89616_CR24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jnnp.2006.104828","volume":"79","author":"G Logroscino","year":"2008","unstructured":"Logroscino, G. et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J. Neurol. Neurosurg. Psychiatry. 79, 6\u201311 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"89616_CR25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1474-4422(17)30401-5","volume":"17","author":"R Chia","year":"2018","unstructured":"Chia, R., Chi\u00f2, A. & Traynor, B. J. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 17, 94\u2013102 (2018).","journal-title":"Lancet Neurol."},{"key":"89616_CR26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s10038-022-01055-8","volume":"68","author":"N Suzuki","year":"2023","unstructured":"Suzuki, N., Nishiyama, A., Warita, H. & Aoki, M. Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy. J. Hum. Genet. 68, 131\u2013152 (2023).","journal-title":"J. Hum. Genet."},{"key":"89616_CR27","doi-asserted-by":"publisher","first-page":"e100125e1","DOI":"10.1371\/journal.pgen.1001257","volume":"6","author":"H Plun-Favreau","year":"2010","unstructured":"Plun-Favreau, H. et al. Cancer and Neurodegeneration: between the devil and the deep blue sea. PLoS Genet. 6, e100125e1\u2013e8. https:\/\/doi.org\/10.1371\/journal.pgen.1001257 (2010).","journal-title":"PLoS Genet."},{"key":"89616_CR28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10522-014-9523-2","volume":"15","author":"JA Driver","year":"2014","unstructured":"Driver, J. A. Inverse association between cancer and neurodegenerative disease: a review of the epidemiologic and biological evidence. Biogerontology 15, 547\u2013557 (2014).","journal-title":"Biogerontology"},{"key":"89616_CR29","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1007\/s00018-019-03428-3","volume":"77","author":"J Seo","year":"2020","unstructured":"Seo, J. & Park, M. Molecular crosstalk between cancer and neurodegenerative diseases. Cell. Mol. Life Sci. 77, 2659\u20132680 (2020).","journal-title":"Cell. Mol. Life Sci."},{"key":"89616_CR30","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/jnnp-2018-319089","volume":"90","author":"PR Mehta","year":"2019","unstructured":"Mehta, P. R. et al. Younger age of onset in familial amyotrophic lateral sclerosis is a result of pathogenic gene variants rather than ascertainment bias. J. Neurol. Neurosurg. Psychiatry. 90, 268\u2013271 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89616-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89616-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89616-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T06:42:19Z","timestamp":1743662539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89616-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["89616"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-89616-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"4 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. D\u2019Amico reports no conflict of interest related to this work; Dr. Cucunato reports no conflict of interest related to this work; Prof. Salemi reports no conflict of interest related to this work; Prof. Aridon reports no conflict of interest related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11189"}}